Literature DB >> 35284506

Regional differences: clinical practice guidelines on the management of hepatocellular carcinoma.

Yuquan Qian1, Andreas Teufel1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35284506      PMCID： PMC8847851          DOI： 10.21037/hbsn-21-496

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  6 in total

1.  Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Authors:  Richard S Finn; Shukui Qin; Masafumi Ikeda; Peter R Galle; Michel Ducreux; Tae-You Kim; Masatoshi Kudo; Valeriy Breder; Philippe Merle; Ahmed O Kaseb; Daneng Li; Wendy Verret; Derek-Zhen Xu; Sairy Hernandez; Juan Liu; Chen Huang; Sohail Mulla; Yulei Wang; Ho Yeong Lim; Andrew X Zhu; Ann-Lii Cheng
Journal:  N Engl J Med       Date:  2020-05-14       Impact factor: 91.245

2.  Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.

Authors:  Gian Paolo Caviglia; Maria Lorena Abate; Elisa Petrini; Silvia Gaia; Mario Rizzetto; Antonina Smedile
Journal:  Hepatol Res       Date:  2015-07-06       Impact factor: 4.288

Review 3.  2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.

Authors:  Di-Yang Xie; Zheng-Gang Ren; Jian Zhou; Jia Fan; Qiang Gao
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

4.  The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States.

Authors:  Nabihah Tayob; Fasiha Kanwal; Abeer Alsarraj; Ruben Hernaez; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-03       Impact factor: 13.576

5.  Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.

Authors:  Nabihah Tayob; Anna S F Lok; Kim-Anh Do; Ziding Feng
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-07       Impact factor: 11.382

6.  GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.

Authors:  Jan Best; Lars P Bechmann; Jan-Peter Sowa; Svenja Sydor; Alexander Dechêne; Kristina Pflanz; Sotiria Bedreli; Clemens Schotten; Andreas Geier; Thomas Berg; Janett Fischer; Arndt Vogel; Heike Bantel; Arndt Weinmann; Jörn M Schattenberg; Yvonne Huber; Henning Wege; Johann von Felden; Kornelius Schulze; Dominik Bettinger; Robert Thimme; Friedrich Sinner; Kerstin Schütte; Karl Heinz Weiss; Hidenori Toyoda; Satoshi Yasuda; Takashi Kumada; Sarah Berhane; Marc Wichert; Dominik Heider; Guido Gerken; Philip Johnson; Ali Canbay
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-08       Impact factor: 11.382
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.